TargetMol

Nolomirole

Product Code:
 
TAR-T33711
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33711-5mg5mg£790.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33711-50mg50mg£1,982.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33711-100mg100mg£2,560.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Nolomirole is a dopamine receptor agonist that reduces symptoms of congestive heart failure caused by monoclinine.
CAS:
90060-42-7
Formula:
C19H27NO4
Molecular Weight:
333.428
Purity:
0.98
SMILES:
CNC1CCc2c(C1)ccc(OC(=O)C(C)C)c2OC(=O)C(C)C

References

Cleland JG, Coletta AP, Clark AL, Velavan P, Ingle L. Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA. Eur J Heart Fail. 2005 Aug;7(5):937-9. PubMed PMID: 16048744. Andersson C, Gislason GH, Weeke P, Kjaergaard J, Hassager C, Akkan D, M?ller JE, K?ber L, Torp-Pedersen C; EchoCardiography and Heart Outcome Study (ECHOS) investigators. The prognostic importance of a history of hypertension in patients with symptomatic heart failure is substantially worsened by a short mitral inflow deceleration time. BMC Cardiovasc Disord. 2012 Apr 25;12:30. doi: 10.1186/1471-2261-12-30. PubMed PMID: 22533520; PubMed Central PMCID: PMC3470965. Kjaergaard J, Akkan D, Iversen KK, K?ber L, Torp-Pedersen C, Hassager C. Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail. 2007 Jun-Jul;9(6-7):610-6. Epub 2007 Apr 25. PubMed PMID: 17462946. Torp-Pedersen C, K?ber L, Carlsen JE, Akkan D, Bruun NE, Dacoronias D, Dickstein K, Haghfelt T, Ohlin H, McMurray JJ. A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. Eur J Heart Fail. 2008 Jan;10(1):89-95. doi: 10.1016/j.ejheart.2007.10.012. Epub 2007 Dec 27. PubMed PMID: 18164245.